Lynch Samuel Eugene 4
4 · BIOMIMETIC THERAPEUTICS, INC. · Filed Mar 28, 2012
Insider Transaction Report
Form 4
Lynch Samuel Eugene
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2012-03-23$2.35/sh+10,000$23,500→ 1,166,691 total - Purchase
Common Stock
2012-03-23$2.35/sh+450$1,058→ 5,550 total(indirect: By Spouse) - Purchase
Common Stock
2012-03-23$2.35/sh+2,700$6,345→ 1,169,391 total
Footnotes (1)
- [F1]Dr. Lynch disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.